Quest Diagnostics stock soared over 8% after beating expectations with a stronger-than-anticipated financial forecast, fueled by a 10% revenue jump in Q2 to $3 billion—driven by new partnerships, direct-to-consumer growth, and wellness tech sales. Automation and AI investments are boosting efficiency, leading to a 19% surge in EPS to $3.12. The company now projects $12 billion in annual revenue and $11.05–$11.25 EPS, signaling confidence in its expanding role in America’s health-focused future.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
